Patents by Inventor Joshua J. CARDIEL RIVERA

Joshua J. CARDIEL RIVERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250144622
    Abstract: In biosciences and related fields, it can be useful to study cells in isolation so that cells having unique and desirable properties can be identified within a heterogenous mixture of cells. Processes and methods disclosed herein provide for encapsulating cells within a microfluidic device and assaying the encapsulated cells. Encapsulation can, among othere benefits, facilitate analyses of cells that generate secretions of interest which would otherwise rapidly diffuse away or mix with the secretions of other cells.
    Type: Application
    Filed: November 14, 2024
    Publication date: May 8, 2025
    Inventors: Volker L.S. KURZ, Jason M. MCEWEN, Kellen C. MOBILIA, Alexander J. MASTROIANNI, Joshua J. CARDIEL RIVERA
  • Patent number: 12179191
    Abstract: In biosciences and related fields, it can be useful to study cells in isolation so that cells having unique and desirable properties can be identified within a heterogenous mixture of cells. Processes and methods disclosed herein provide for encapsulating cells within a microfluidic device and assaying the encapsulated cells. Encapsulation can, among other benefits, facilitate analyses of cells that generate secretions of interest which would otherwise rapidly diffuse away or mix with the secretions of other cells.
    Type: Grant
    Filed: February 10, 2023
    Date of Patent: December 31, 2024
    Assignee: Bruker Cellular Analysis, Inc.
    Inventors: Volker L. S. Kurz, Jason M. McEwen, Kellen C. Mobilia, Alexander J. Mastroianni, Joshua J. Cardiel Rivera
  • Publication number: 20230313107
    Abstract: Cartridge for manufacturing a population of cells suitable for formulation as a cellular therapeutic are disclosed herein, along with systems for operating the cartridges and performing methods to generate the population of cells suitable for formulation as a cellular therapeutic. The population of cells suitable for formulation as a cellular therapeutic can be T-cells, including CAR T-cells. The systems and methods can be largely automated.
    Type: Application
    Filed: December 28, 2022
    Publication date: October 5, 2023
    Applicant: BERKELEY LIGHTS, INC.
    Inventors: Andrew W. McFarland, Peter J. Beemiller, Guido K. Stadler, Alexander J. Mastroianni, Joshua J. Cardiel Rivera, Darcy K. Kelly-Greene, Jonathan Cloud Dragon Hubbard, Natalie C. Marks, Long Van Le, Ke-Chih Lin
  • Publication number: 20230201827
    Abstract: In biosciences and related fields, it can be useful to study cells in isolation so that cells having unique and desirable properties can be identified within a heterogenous mixture of cells. Processes and methods disclosed herein provide for encapsulating cells within a microfluidic device and assaying the encapsulated cells. Encapsulation can, among other benefits, facilitate analyses of cells that generate secretions of interest which would otherwise rapidly diffuse away or mix with the secretions of other cells.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 29, 2023
    Inventors: Volker L.S. KURZ, Jason M. MCEWEN, Kellen C. MOBILIA, Alexander J. MASTROIANNI, Joshua J. CARDIEL RIVERA
  • Patent number: 11612890
    Abstract: In biosciences and related fields, it can be useful to study cells in isolation so that cells having unique and desirable properties can be identified within a heterogenous mixture of cells. Processes and methods disclosed herein provide for encapsulating cells within a microfluidic device and assaying the encapsulated cells. Encapsulation can, among other benefits, facilitate analyses of cells that generate secretions of interest which would otherwise rapidly diffuse away or mix with the secretions of other cells.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: March 28, 2023
    Assignee: Berkeley Lights, Inc.
    Inventors: Volker L. S. Kurz, Jason M. McEwen, Kellen C. Mobilia, Alexander J. Mastroianni, Joshua J. Cardiel Rivera
  • Publication number: 20220325240
    Abstract: Cartridges for manufacturing a population of cells suitable for formulation as a cellular therapeutic are disclosed herein, along with systems and instruments for operating the cartridges and performing methods to generate the population of cells suitable for formulation as a cellular therapeutic. The population of cells suitable for formulation as a cellular therapeutic can be immunological cells, such as T lymphocytes, including endogenous T cells (ETCs), tumor infiltrating lymphocytes (TILs), CAR T-cells, TCR engineered T-cells, or otherwise engineered T-cells. The systems and methods can be largely automated.
    Type: Application
    Filed: January 12, 2022
    Publication date: October 13, 2022
    Inventors: Andrew W. McFarland, Peter J. Beemiller, Guido K. Stadler, Alexander J. Mastroianni, Joshua J. Cardiel Rivera, Darcy K. Kelly-Greene, Jonathan Cloud Dragon Hubbard, Natalie C. Marks, Long Van Le, Ke-Chih Lin
  • Publication number: 20220161255
    Abstract: In biosciences and related fields, it can be useful to study cells in isolation so that cells having unique and desirable properties can be identified within a heterogenous mixture of cells. Processes and methods disclosed herein provide for encapsulating cells within a microfluidic device and assaying the encapsulated cells. Encapsulation can, among other benefits, facilitate analyses of cells that generate secretions of interest which would otherwise rapidly diffuse away or mix with the secretions of other cells.
    Type: Application
    Filed: October 28, 2021
    Publication date: May 26, 2022
    Inventors: Volker L.S. KURZ, Jason M. MCEWEN, Kellen C. MOBILIA, Alexander J. MASTROIANNI, Joshua J. CARDIEL RIVERA